Georgia Southern University

Digital Commons@Georgia Southern
Electronic Theses and Dissertations

Graduate Studies, Jack N. Averitt College of

Spring 2017

Assessment of Short-Term Toxicity of Titanium Dioxide
Nano Fiber (TDNF) in Sprague Dawley Rats
Daniel A. Hunter

Follow this and additional works at: https://digitalcommons.georgiasouthern.edu/etd
Part of the Other Chemistry Commons

Recommended Citation
Hunter, Daniel A., "Assessment of Short-Term Toxicity of Titanium Dioxide Nano Fiber
(TDNF) in Sprague Dawley Rats" (2017). Electronic Theses and Dissertations. 1570.
https://digitalcommons.georgiasouthern.edu/etd/1570

This thesis (open access) is brought to you for free and open access by the Graduate Studies, Jack
N. Averitt College of at Digital Commons@Georgia Southern. It has been accepted for inclusion in
Electronic Theses and Dissertations by an authorized administrator of Digital Commons@Georgia
Southern. For more information, please contact digitalcommons@georgiasouthern.edu.

ASSESSMENT OF SHORT-TERM TOXICITY OF TITANIUM DIOXIDE
NANO FIBER (TDNF) IN SPRAGUE DAWLEY RATS
by
DANIEL HUNTER
(Under the Direction of Worlanyo Gato)

ABSTRACT
Nanotechnology is easily becoming one of the fastest growing markets around the globe.
Synthetic nanomaterials have many unique chemical and physical properties, mainly due to their
huge specific surface area and chemical makeup. Specifically, titanium dioxide (TiO2)
nanomaterials have high stability, anticorrosive and photocatalytic properties. These
nanomaterials have applications for semiconductor photocatalysis, treatment of water, as a
photoactive material in nanocrystalline solar cells, and medicine. However, not much is known
about the toxicity of TiO2 in the nanofiber form. The objective of the present study is to
investigate the adverse effects associated with acute ingestion of TiO2 nanofiber (TDNF). TDNF
was fabricated via an electrospinning method, followed by dispersion in water. Six to seven
week old male Sprague Dawley rats were exposed to a total of 0, 40 and 60 ppm of TDNF for
two weeks via oral gavage. Weight gain and cumulative weight eaten was tracked during the
course of the study, displaying statistically insignificant concentration-dependent alterations
among the three treatment groups. Differences in organ weights were not statistically significant
among treatment groups. Blood serum was tested for Albumin, Alanine aminotransferase, and
Lactase dehydrogenase to detect tissue damage in the lungs, liver, and kidney. Results from the

blood serum indicated possible damage with respect to the kidney and liver. These findings were
followed by global gene expression analysis to identify which transcripts might be responsive to
TNDF toxicity. Differentially expressed mRNA levels among the liver, kidney, and lung yielded
interesting results. Further analysis is needed to interpret what is being done to the tissue. One
theory is the fact that TNDF is unable to penetrate the cell as a result; it forms a phagocytosis site
and thus triggers inflammatory and immune response. All results taken together, short-term
ingestion of titanium dioxide nano fiber (TNDF) produced marginal effects indicative of toxicity.

KEYWORDS: Nanomaterials, Titanium dioxide, Gene expression, Blood serum, Toxicity

ASSESSMENT OF SHORT-TERM TOXICITY OF TITANIUM DIOXIDE
NANO FIBER (TDNF) IN SPRAGUE DAWLEY RATS
by
DANIEL HUNTER
B. S., Georgia Southern University, 2014
A Dissertation Submitted to the Graduate Facility of Georgia Southern University in Partial
Fulfillment of the Requirements for the Degree
MASTER OF SCIENCE
STATESBORO, GEORGIA

© 2017
DANIEL HUNTER
All Rights Reserved

1

ASSESSMENT OF SHORT-TERM TOXICITY OF TITANIUM DIOXIDE
NANO FIBER (TDNF) IN SPRAGUE DAWLEY RATS
by
DANIEL HUNTER

Major Professor: Worlanyo Gato
Committee: Amanda Stewart
Ji wu
Electronic Version Approved:
May 2017

2

TABLE OF CONTENTS
Page
List of Tables……………………………………………………………………………...4
List of Figures……………………………………………………………………………..5
CHAPTERS
1 Backgroung/ Introductions………………………………………………………………6
2 Materials and Methods………………………………………………………………......9
2.1 Synthesis and Characterization………………………………………………..9
2.2 Experimental Design…………………………………………………………..9
2.3 Why In Vivo?...................................................................................................10
2.4 Microarray Experiment……………………………………………………....10
2.5 Quantitative PCR…………………………………………………………….11
2.6 Clinical Serum.................................................................................................12
2.6.1 Total Protein……………………………………………………….12
2.6.2 Albumin……………………………………………………………12
2.6.3 Alanine Aminotransferase…………………………………………12
2.6.4 Lactase Dehydrogenase……………………………………………13
2.6.5 Igha Levels in Liver………………………………………………..13
2.7 Data Analysis………………………………………………………………...14
3 Results and Discussion………………………………………………………………...15
3.1 Characterization of TiO2 Nanofibers………………………………………...15
3.2 TDNF Effect on Morphometric Indices……………………………………...19
3.3 TDNF Effects in the Kidney…………………………………………………28

3

3.3.1 Histopathology of the Kidney……………………………………...28
3.3.2 Serum Levels of Lactate Dehydrogenase………………………….28
3.3.3 Selected Inflammatory mRNA Levels in response to TDNF
Ingestion……………………………………………...……………………….……….29
3.4 TDNF Effects in the Liver…………………………………………………...33
3.4.1 Histopathology of the Liver………………………………………..33
3.4.2 Serum Levels of Alanine Aminotransferase and Albumin………...33
3.5 TDNF Effects in the Lung…………………………………………………...38
3.5.1 Histopathology of the Lung………………………………………..38
3.5.2 Serum Total Protein………………………………………………..38
3.5.3 Assessing Genome-wide Effect of TNDF…………………………39
3.5.4 Igha mRNA Levels in response to TDNF Ingestion……………….40
4 Summaries and Conclusions…………………………………………………………...51
4.1 Kidney Effects……………………………………………………………….51
4.2 Liver Effects…………………………………………………………………51
4.3 Lung Effects…………………………………………………………………52
References……………………………………………………………………………….53

4

List of Tables
TABLE
1. Feed Efficiency…………………………………………………………………………..24
2. Alanine Aminotransferase and Albumin Blood Serum Levels………………………….36
3. Primer Sequences of 11 genes studied…………………………………………………..37
4. Select number of altered mRNA transcripts between the groups……………………….46
5. Pathway Assessment via Gene Expression……………………………………………...48

5

List of Figures
FIGURES
1. BET Surface Area/ BJH pore size distribution…………………………………………16
2. SEM images of Purified TDNF………………………………………………………...17
3. Cumulative Distribution of Fiber Diameter…………………………………………….18
4. Cumulative Amount of Dietary Ingestions……………………………………………..22
5. Average Weight of Rodents During Treatment Period…………………………………23
6. Mean Kidney Weights…………………………………………………………………..25
7. Mean Lung Weights…………………………………………………………………….26
8. Mean Liver Weights…………………………………………………………………….27
9. H&E Images of Kidneys………………………………………………………………..30
10. Amount of LDH in Blood Serum……………………………………………………….31
11. Relative mRNA Expression of Select Genes in Kidney………………………………..32
12. H&E Images of Liver…………………………………………………………………...35
13. H&E Images of Lungs…………………………………………………………………..42
14. Total Protein Concentration in Blood Serum…………………………………………….43
15. Volcano Plot of Lung Differentially Expressed genes from TDNF……………………..44
16. Venn Diagram Connection of Altered Genes Among Groups…………………………..45
17. qRT-PCR of Igha………………………………………………………………………...50

6

Chapter 1: Background/Introduction
The past decade has seen an explosive growth in the synthesis and use of engineered
nanomaterials (ENMs).1 ENMs have applications in various kinds of materials and processes
because of their unique electrical, magnetic, optical, and catalytic properties.2 Titanium dioxide
nanoparticles (TDNP) are one of the most produced ENMs in the past. This is largely due to the
unique characteristics that TDNP exhibit, including photocatalysis, high refractive indices,
excellent anticorrosive properties, etc.3 These characteristics allowed TDNP’s to be applied in all
fields of science such as electronics, transportation, telecommunication, imaging, biomedical,
pollution, medication, cosmetics, coatings, etc.4 This has led to a growth of studies that examined
the toxicity of titanium dioxide in its nanoparticle form.5 Previous research has shown that TiO2
can be dangerous in in vitro models. For instance, a study a few years ago found that exposure of
BEAS-2B cells to TiO2 nanoparticles induced apoptosis and oxidative stress.6 Another study
investigated the effect of TiO2 NPs on human astrocyte and neuronal cells after acute and longterm exposure.7 Both acute and prolonged exposures, even at low dose, seem to affect the
proliferative capacity of the cells. The authors found toxicological effects on the central nervous
system (CNS). However, there are very little studies that have examined ENMs in their fiber
form, such as the titanium dioxide nano fiber (TDNF).
TDNFs share the same chemical properties as TDNPs except for shape and can be found
in common household products such as cosmetics, certain food, rubber, etc.4c Since these
products are used frequently, contact is inevitable. Interestingly enough, the shape of the ENM
plays a crucial role in nanotoxicity, as nanofibers, in theory, have a greater resistance to be
broken down by an organism’s internal resistance. For example, macrophages can envelope
nanoparticles and essentially digest them; however, the length of the nanofibers are long enough
to prevent a macrophage from breaking them down and even has a chance to lyse open the
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macrophage.8 Thus, it is essential that the toxic impact of TDNF on human health be studied
thoroughly. Recent studies have shown that ENM’s can have great potential to be toxic when
introduced to the environment.9 Another study has shown that a buildup of TDNF in the body
can cause all sorts of problems like increased generation of reactive oxygen species (ROS) and
inflammation and increased lipid peroxidation.8, 10 One can assume that the toxicity of
nanoparticles varies depending on type of ENM, exposure route and size of the material, which
causes inconsistent results in ENM toxicity.3b The goal of the present study is to investigate the
short-term effects of titanium dioxide nanofibers on the kidneys, liver, and lungs of male
Sprague Dawley rats.
All organs are vital in the human body and the kidney is no exception. The kidneys are
responsible for filtering out the blood by removing wastes. The kidney controls the body’s fluid
balance and also regulates the balance of electrolytes.11 As nanoparticles enter the body they are
small enough to enter the bloodstream, which makes contact with the kidneys a sure thing.12 One
study indicates that when Wistar rats were given palladium nanoparticle doses, the kidneys had
suffered severe renal tubular dysfunction. ENM induced toxicity to the kidney can be very
dangerous and very hard to detect, requiring multiple analytical techniques.13
The liver, like the kidney, is responsible for filtering out the blood; however, unlike the
kidney the blood is filtered from the digestive track before passing on to the rest of the body.
Hepatic function also includes detoxing chemicals and metabolizing drugs, making them the
object of focus in toxicological examinations.
The lungs are a vital part of life for land animals, as they provide the body with oxygen
by storing it via the alveoli in our lungs. Lungs are observed when doing toxicological studies
with macro-drugs, even more so, with ENMs being prime candidates for drug delivery systems.
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Since translocation of drugs is a vital part of toxicological studies, especially with ENMs since
their high surface area to size ratio, it is important to see if it is possible for TDNF to access
areas of the body not associated with the digestive tract.
This study aims for a better understanding on the renal, hepatic, and lung deficiencies of
oral ingestion of TDNF in Sprague Dawley rats, using a variety of analytical tools and
techniques. Gene expression analysis of transcripts involved in inflammation, apoptosis, cell
growth regulation, stressors and immune response were undertaken. Furthermore, rat
morphometric indices, scanning electron micrograph (SEM) and histopathology of renal tissues
were performed to further characterize tissue damage via TDNF ingestion.
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Chapter 2: Materials and Methods
2.1 Synthesis and Characterization
The fabrication of titanium dioxide nanofibers (TiO2 NF) began with mixing ~1 gram of
polyvinylpyrrolidone (PVP) with 10 mL of ethanol. In a separate container ~3 grams of TiIP
(titanium iso-propoxide) was mixed with 5 mL of ethanol and 3 mL of Acetic Acid. These
solutions were vortexed separately for ~ 30 minutes to ensure thorough mixing. The solutions
were then added together and vortexed again for another 5 minutes. This mixture was then
sonicated for 20 minutes before electrospinning. Once the gelation of the intended nanofiber
solution was completed, it was ready for electrospinning. The parameters of electrospinning were
as follows: the distance from the end of the syringe to the grounding aluminum collector was 1215 cm. The pumping rate of sol-gel solution was 5 mL/hr. The applied DC voltage was 25 kV.
Once all the sol-gel solution had been electrospun, fabricated fibers were left overnight for
complete gelation. These nanofibers were annealed at ~565°C in air for roughly 12 hours. A
Field Emission Electron Microscopy (JEOL JSM-7600F) attached with Transmission Electron
Detector (TED) was utilized for morphology and structural characterization. Once the inorganic
TiO2 nanofibers were fabricated and purified, scanning electron microscopy (SEM) and BrunaurEmmett-Teller instruments was used to characterize the fibers.

2.2 Experimental Design
Twelve male Sprague Dawley rats were purchased from Taconic Bioscience Inc., Hudson
NY. The rats randomly selected into three treatment groups: control (0ppm), Low (40ppm),
Medium (60ppm). The rats (6-7 weeks old) were given treatment specific doses of titanium, via
oral gavage, two times a week for two weeks. During the treatment period the weights of the
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animals and dietary statistics were taken. At the end of the treatment period the rats were
euthanized and blood was collected via cardiac puncture. Most of the kidney, liver, and lungs
were extracted and preserved with liquid nitrogen, while a small fraction was submerged in a
10% formalin solution for histology and haemotoxylin and eosin (H&E) staining.
Animals were housed at the Georgia Southern University Animal Facility (1176A
Biological Sciences Fieldhouse). This facility is accredited by Association for Assessment and
Accreditation of Laboratory Animal Care (AAALAC). Rats were treated according to the
principles outlined in the ILAR’s (Institute for Laboratory Animal Research) Guide for Care and
Use of Laboratory Animals. Protocols were reviewed and approved by Institutional Animal Care
and Use Committee (IACUC protocol# I15002). Care was taken to minimize the number of
animals employed in the research as well as minimizing animal discomfort.

2.3 Why In Vivo?
The In vivo testing method was used as it accurately simulates an organism’s biological
environment; however, it should be noted that it is rather difficult to extrapolate data from a
rodent and apply it to humans.

2.4 Microarray Experiment
Total RNA was converted to single-stranded sense-target, fragmented, labeled, and hybridized to
the Affymetrix Rat Gene ST 2.0 microarray according to the manufacturer’s protocol
(Affymetrix, Catalog no. 902280). The labeling kit is the GeneChip® WT PLUS Reagent Kit
(Affymetrix, catalog no. 902414). After hybridization, arrays were washed on the Affymetrix
450S Fluidics unit and scanned using the Affymetrix 7G scanner as described in Affymetrix
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GeneChip™ Wash, Stain and Scan protocol (Affymetrix, 2008). The Rat Gene ST 2.0 chip
contains over 27,000 protein-coding transcripts and over 24,000 Entrez genes. Microarray was
used to determine gene expression levels of select genes transcripts.

2.5 Quantitative PCR
Quantitative PCR was used to determine changes in genotypic expression. Quantitative
measurement of Igha, CD209, Hepacam2, Rgs13, IgG2a, TNF-α, IL-1β, NF-kB, p53, p21,
Gadd45α and β-actin as control gene. These transcripts play such cellular roles as immune
response, DNA transcription and recombination, regulating cell division, negatively regulating
G-protein signal pathways, and cell structure and motility. Quantification of the transcripts was
measured using quantitative real-time polymerase chain reaction (RT-qPCR) using β-actin as a
control gene. FASTA mRNA sequences of these mRNA transcripts were obtained for Rattus
Norvegicus using the National Center for the Biotechnology Information (NCBI) database.
Forward and reverse primers for the genes were then generated using NCBI Primer-Blast. Primer
sequences were shown in Table 1. Primers were purchased from Integrated DNA Technologies
Inc (IDT), Coralville IA USA.
Total RNA was extracted from rat livers using a Qiagen miRNEAsy mini kit
(Qiagen, Catalog no. 217004). Approximately 30 mg kidney samples were homogenized in
Qiazol buffer. Qiazol buffer denatures and inactivates RNases, separating RNA into the aqueous
phase and DNA and proteins into the organic phase. The aqueous phase with RNA is then
allowed to bind to a silica-gel membrane, DNAse treated, washed, and finally eluted with
RNase-free water. Total RNA was quantified using the UV-vis spectrophotometer at 260 and
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280 nm absorbance. RNA integrity was evaluated on the Agilent 2100 Bioanalyzer 6000 Nano
assay (Agilent, catalog no. 5067-1511).

2.6 Clinical Serum
2.6.1 Total Protein
In this experiment, serum total protein was quantified using Randox Monza Chemistry analyzer
instrument (Kearneysville WV). The assay was performed according to the Randox’s total
protein biuret assay guidelines. Briefly, standards and samples were prepared according to the
manufacturer’s protocol and quantified on the instrument at a wavelength of 546 nm.

2.6.2 Albumin
The Shimadzu UV-VIS Recording Spectrophotometer was used to quantify the amount of
albumin (ALB) in the blood serum. Method of ALB determination was used with the
bromocresol green (BCG) method; 10 μl of sample was mixed with 1ml of BCG. Absorbance
was taken within 90 seconds of mixing at 630 nm at a constant temperature of 37 oC.
Concentration of ALB was calculated using linear extrapolation via ALB standard curve; using
the BCG reagent as a blank and a 6g/dL ALB solution as the upper limit.

2.6.3 Alanine Aminotransferase
The RX Monza was used to quantify the amount of alanine aminotransferase (ALT) in the blood.
RX Monza was calibrated with a Calibration Serum Level 3 (CAL 3) from Randox Laboratory.
The CAL 3 serum had to be primed before use; therefore, 5ml of DI water was added to the CAL
3 powdered mix and was left in darkness for 30 mins. ALT kit from Randox was used to
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determine ALT levels. ALT reagent was prepared by mixing 2 ml of R1a with R1b, from the
ALT kit. The upper calibration limit was prepared using 50 μl of CAL 3 solution with 500ul of
R1a/b solution (1:10 sample to reagent ratio). The blank used was just the R1a/b mixture by
itself. RX Monza used linear calibration to determine ALT levels in sample.

2.6.4 Lactase Dehydrogenase
The Rx Monza analyzer (Randox Laboratories, Kearneysville WV) was employed to
quantitatively determine the amount of lactase dehygrogenase (LDH) in the blood serum. LDH
test was optimized using LDH Pyruvate-L-lactated kit from Randox laboratories (Kearneysville
WV). Rx Monza instrument was calibrated using the CAL 3 serum (Cat#: CAL2351). Once
calibrated, the LDH reagent was prepared by mixing one vial of R1b with 3ml of R1a from the
LDH Randox kit. Samples were prepared and measured according to guidelines provided
Randox laboratories (Kearneysville WV).

2.6.5 Igha Levels in Liver
Quantification of Igha was measured using quantitative real-time polymerase chain reaction
(qRT-PCR) using β-actin as a control gene. FASTA mRNA sequences of these mRNA
transcripts were obtained for Rattus norvegicus using the National Center for the Biotechnology
Information (NCBI) database. Forward and reverse primers for the genes were then generated
using NCBI Primer-Blast. Primer sequences were shown in Table 3. Primers were bought from
Integrated DNA Technologies Inc (IDT), Coralville IA USA.
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2.7 Data Analysis
The .cel files were loaded into Partek® Genomics Suite 6.6 (Partek Inc. 2015, St Louis
MO) for derivation of quality control metrics to ensure data integrity and validity. Quality
control parameters were within normal range as such none of the .cel data was excluded. Data
was then subjected to a mixed model analysis of variance (ANOVA). Significantly (p < 0.05)
differentially expressed genes between control and treated groups and fold change > 2 or fold
change < -2 were calculated. False discovery rate (FDR) was 1 %.
Statistical analyses were performed on body and organ weights to assess significant
changes in treated groups in comparison to the control animals. Random trend model was
employed to test the overall effect from the ingestion of TNDF. All statistical analyses were
performed using Statistical Analysis System (SAS) software version 9.3. The data was presented
as the mean ± standard error.
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Chapter 3: Results and Discussion
3.1 Characterization of TiO2 Nanofibers
Characterization of TDNF was assessed using BET and SEM. Translocation pathways of
nanofibers in vivo are still not well known. Characterizing the size and shape of ENMs,
especially nanofibers, can help ease the way for a more solid understanding ENM translocation.
BET data in Figure 1A shows that the surface areas of the fibers were 6.63m2/g. Figure 1B
illustrated that not only were the fibers porous, but the fibers contained more smaller pores than
larger pores. The length of titanium dioxide nanofibers ranged from 2-50 μm, which was
acquired via several SEM images one of which was Figure 2A. These images, in conjunction
with the image-j program, were used to determine the diameter of the fibers, which ranged from
45nm ≤x≤ 917nm (Figure 3). Recent studies on shape-induced toxicity by titanium dioxide
nanofibers have shown a positive relationship on abnormal macrophage morphology with an
increase in nanofiber length.14
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Figure 1. Using the equation from the BET Plot (Left-A) the surface area for the fibers can be
calculated. The BJH Pore Size Distribution (Right-B) provides the density of pore sizes within
the fibers.
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A: TiO2 nano fiber (TNDF) x7000

B: TiO2 nano fiber (TNDF) x10000

C: TiO2 nano fiber (TNDF) x130000

Figure 2. SEM images of Purified TDNF at 7000x (A), 10000x (B), and 130000x (C)
magnification.

Cumulative Distribution
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Figure 3. Cumulative Distribution of Fiber Diameter acquired through Image J program using
various SEM images of the nanofibers.

19

3.2 TDNF Effect on morphometric indices
There is enough evidence to suggest TiO2 NPs might negatively impact human health.
However most of the studies involving TiO2 nanomaterial toxicity comprised in vitro models. It
is quite a task to make the case for health concerns based solely on cell culture data. In general,
exposure to environmental contaminants produces varying effects on body weight gain.
Depending on the toxicant, overall body weight can be reduced or significantly increased
between control and exposed groups.15
The effects of TDNF consumption on amount of diet ingested (Figure 4), weight gain
(Figure 5), Feed efficiency (Table 1), and kidney, lung, and liver weights (Figure 6, 7, 8) were
measured. The rats were allowed a surplus of food and water to last for 2-3 days. At the end of
the 2-3 days the water and food were replenished; the feed was filled to ~200g. Due to natural
growth and a sedentary lifestyle the amount of food eaten will increase. Around the second
weighing period, according to Figure 4, there is a slight nuance in the difference of cumulative
food eaten between the control group and the groups that ingested TDNF (40ppm and 60ppm).
However, in the third and fourth weighting periods the difference increases by 60% and then by
90%, with referencing to the second weighting period. There seems to be a small trend in eating
habits and ingestion of TDNF; however, there is a lack of supporting evidence from studies
showing any such correlation.
The acute effect of TDNF ingest was examined in male Sprague Dawley rats. Exposure
to TDNF could result in weight loss. Shown in Figure 5 is the mean weight of the rodents over
the course of the study. The overall spaghetti plot showed that all the rats gained weight over
time. As anticipated, animals gained weight during treatment. However, the mean weight gain
varied depending on the amount of TDNF ingested. At the beginning of the treatment period,
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cumulative weight of the control group was least in comparison to the rest. As time went on
though, TDNF exposed groups began to reveal slightly reduced weight. By the end of the
treatment period, there was a marginal difference between the control animals and TDNF
consumed rats.
Feed efficacy (Table 1), the interpretation of how well an animal can convert feed into a
desired product was calculated among the three treatment groups; however, the rats were not
producing a desired product. Feed efficiency in this study was to see how much feed was
converted into body weight. Looking at the FE*100 column of Table 1, among the three
treatment groups 50-60% of what was eaten was converted into body weight. However, the
differences among the groups was deemed not significant via one-way ANOVA (F(2,9) = 1.204,
p= 0.344).
ENMs have an increased size to surface area ratio. In theory, the nanofibers should be
small enough to infiltrate and translocate into various organs via bloodstream. For this reason
weight measurement of various organs like the kidney, lungs, and liver were taken. Figure 6
shows the weights of the kidneys of the three treatment groups. The figure depicts a small
decrease in average kidney weight as ingestion of TDNF increases. However, the weight change
is not significant according to statistical analysis. The weight of the lung was measured after
euthanasia. Animals in the control group had the highest mean of lung weight, followed by the
medium group rats, with the low concentration TDNF rats showing the lowest lung weights
(Figure 7). The weights of the livers, shown in figure 8, were measured on the day of sacrifice.
The control group had the highest liver weights followed by the medium group (60ppm) and
lastly by the low group (40ppm). At first, it appears that TDNF may have some role in weight
loss albeit healthy weight loss or through cytotoxicity. However, upon statistical evaluation
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(ANOVA) differences among the three treatment groups are not significant. Furthermore,
histopathology rules out any serious tissue damage that would result in weight loss of the liver.
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Figure 4. Cumulative amount of dietary ingestions over the course of the study. Treated groups
seem to consume less of the diet over time.

Weight (g)
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Figure 5. Average weight±SE of male Sprague Dawley rats over the course of the study. Weight
measurements were performed nine times for two plus weeks. The horizontal axis represents
actual weight measurement times. Animals were assigned into dose regimes of treatment 1 (blue
– control, 0 ppm); treatment 2 (red – low concentration, 40 ppm) and treatment 3 (green –
medium concentration, 60 ppm). Weight gain was not significant.
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Table 1. Feed Efficiency Data. This figure depicts how well the rodents can convert food
consumed into body weight and its significance in the differences between them.

Kidney weight (g)
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Figure 6. Mean kidney weights (g) at the time of sacrifice of rats. Data shown as
weight±standard error. Treatments 1, 2 and 3 were 0 ppm; 40 ppm; and 60 ppm TiO2 NF
respectively

Lung weight (g)
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Figure 7. Mean lung weights (g) at the time of sacrifice of rats. Data shown as weight±SE.
Treatments 1, 2 and 3 were control – 0 ppm, low – 40 ppm, and medium – 60 ppm TiO2 NF
respectively.
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Figure 8. Mean Liver weights (g) at the time of sacrifice of rats. Data shown as weight±SE.
Control – 0 ppm, low – 40 ppm, and medium – 60 ppm TiO2 NF respectively.
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3.3 TDNF Effects in the Kidney

3.3.1 Histopathology of the Kidney
Kidney tissue was then prepped for histological testing. The trimming and sectioning of
the tissue was at a thickness of 4 µm and staining was done with hematoxylin and eosin. The
sections were then rated on a scale of 0-3 (0=none, 1-mild, 2= moderate, 3=marked). Assessment
kidney histopathology slides were examined. Figure 9 shows no observable morphological
irregularities in the renal tissues. However, according to some literature titanium dioxide
nanoparticles with sizes of 5 nm or more caused dose dependent inflammatory lesions in rats.4b
One study injected titanium dioxide nanoparticles into zebra fish and found no damage or trauma
to the kidney tissues.16

3.3.2 Serum Levels of Lactate Dehydrogenase (LDH)
LDH is an enzyme that helps the catalysis of pyruvate into lactate, also converting
NAD+ to NADH and back. LDH is released in the presence of damaged cells; therefore, it is
used as a marker for tissue injury and diseases. LDH activity in blood serum was significantly
elevated in animals exposed to TDNF (Figure 10) in a seemingly concentration-dependent
manner. These LDH values ranged from around 450 U/L in the 0 ppm group to over 525 U/L in
both the 40 and 60 ppm animals. LDH levels this high should indicate tissue damage; however,
histology showed no observable abnormalities in the kidney tissue. High levels aside, there seem
to be a dose-dependent relationship between TDNF ingestion between the control group and the
treated groups. Statistical analysis tells that the difference in LDH levels between the control and
treated groups are not significant.
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3.3.3 Selected Inflammatory mRNA Levels in response to TDNF Ingestion
The significant expression of Hepacam2 (Figure 11 panel I) were noted from transcripts
previously identified to be responsive to TDNF ingestion in a prior study. On the contrary,
CD209, IgG-2a, IghA and RgS13 were not significantly changed in renal tissues. With respect to
genes selected based on literature reviews, Gadd45a and NFkB genes were over-expressed in
kidney tissues (Figure 11 panel II). Contrarily, IL-1B and TNFalpha seem to be down-regulated
relative to 0 ppm groups.
Looking at the 11 genes examined, only 3 showed significant signs of over-expression.
NF-KB is a transcription factor that regulates many important pathways such as apoptosis, cell
proliferation, pro-/anti-inflammatory processes. Up-regulation of NF-KB could possibly lead to
uncontrolled cell death or tumorigenesis, two extreme cases on the opposite sides of cell life.
However, this data paired with histology, normal cell counts, and no indication of tumors leads
to the assumption that NF-KB was involved with inflammation in the kidneys. However, a
typical NF-KB inflammation response should correspond to increased levels of IL-1B and TNFα.
Both IL-1B and TNFα help regulate the immune response; therefore, a lack of inflammatory
regulation in conjunction with an over-expression of NF-KB should have shown inflammation in
the histology slides.
Gadd45a is a protein associated with stressful growth arrest conditions and treatment with
DNA-damaging agents. With a small up regulation in both 40 and 60ppm groups, it seems that
Ti-47 may have induced stress on the cells. However, lack of upregulation of p21, another major
protein associated with cell growth arrest, could indicate cell growth arrest pathway independent
of the canonical Gadd45a and p21 pathway. Furthermore, there was no difference in regulation
of this pathway according to the static expression of p53 in both low and medium groups.
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0 ppm TDNF

40 ppm TDNF

60 ppm TDNF

Figure 9. Renal anatomic characterization showing select H&E images of male Sprague Dawley
rats exposed to 0 ppm (control), 40 ppm (low concentration), 60 ppm (medium concentration) for
two weeks via oral gavage.
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Figure 10. Amount of LDH in the serum of animals exposed to TDNF. LDH activity is
significantly increased (p<0.01) in animals that ingest TDNF. Treated groups were 0ppm, 40
ppm, 60 ppm TDNF.
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Figure 11. The relative mRNA expression (ΔCq) of a select genes in the kidneys of rats that
ingested TDNF at 0 ppm (control – FC); 40 ppm (low concentration – FLC) and 60 ppm
(medium concentration – FMC). Gnat3 and and Hepacam2 were differentially expressed.
Significant changes were noted as aP<0.05, P>0.01. Panel I shows genes previously identified
from a study in our laboratory. Panel genes were identified in the literature to be responsive to
TDNF in other systems

33

3.4 TDNF Effects in the Liver

3.4.1 Histopathology of the Liver
The H&E staining of the tissues showed no considerable differences among the three
treatment groups, with respect to liver damage.

3.4.2 Serum Levels of Alanine Aminotransferase and Albumin
Serum levels, specifically albumin (ALB) and alanine aminotransferase (ALT), are
excellent indicators of liver health. Small deviations in the amount of ALB in liver tissue could
mean that the liver were functioning as expected as ALB levels can vary depending on food
consumption; however, large variation of albumin could indicate damage. Likewise, an increase
in the amount of ALT could indicate liver damage. Serum levels of alanine aminotransferase
(ALT) of the control group were substantially higher than those from reference values. When
comparing the serum levels among the three groups there is a dose dependent relationship in
increased TDNF ingestion with decreased ALT levels. The decreased ALT activity in the treated
groups; however, bring the levels within reference values. This could be due to possible serum
contamination from fat cell aggregates or possible cell layer contamination. When looking at the
three groups ANOVA indicated that differences in the ALT activity were significant (pvalue<0.01).
Albumin levels in the control and low groups were within one standard deviation of the
literature value (4.4 ± 0.5). The ALB levels, in the medium dose group, were not statistically
significant with respect to the reference value (Table 2). It is worth noting that the low dose
group was statistically different from the control and medium groups (p=0.0012). However,
Table 2 clearly shows that albumin levels coincide with literature values for rodents. On the
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other hand, ALT levels are extremely high compared to reference values, which could be
interpreted as liver damage.

35

Figure 12. Images of hepatic cells taken from livers of rats in the control (0 ppm TDNF), low
dose (40 ppm TDNF), and medium dose (60 ppm TDNF) groups.
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Table 2. Concentration of ALT and ALB in the control (0 ppm TDNF), low (40 ppm TDNF),
and medium (60 ppm TDNF) exposure groups. Reference values are for ALT and ALB levels in
serum of female rats between 8 and 16 weeks old.17
Reference Mean ± SD control
[ALT] U/L

25 ± 9

[ALB] g/dL 4.4 ± 0.5

low

48.05 ± 1.33 22.04 ± 2.37

medium
19.50 ± 2.38

3.92 ± 0.042 4.47 ± 0.094 3.73 ± 0.17
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Table 3. Primer sequences of the 11 genes studied.
Gene Name

CD209

Igha

IgG-2a

Hepacam2

Rgs13

TNF-α

IL-1β

NF-kB

P53

P21

Gadd45-α

Primer Sequence
Forward

5’CTCCAAATCCCAGCGTAACT3’

Reverse

5’ACAGCAGAGGTCAAGGAAAC3’

Forward

5’TCTGGACCTGAACTGGAGAA3’

Reverse

5’TGGGTAGATGGTGGGATCTT3’

Forward

5’GCCTGGTCAAGGGCTATTT3’

Reverse

5’GTAACTCCCATCTGTGTCCATC3’

Forward

5’GACTGTTCTGCTGACTCTTATCC3’

Reverse

5’CTCTGTGTCGTCTTGCTGTT3’

Forward

5’GTACAACACGGGAAGCTATCA3’

Reverse

5’TAATCATGGGCGTGCTACAG3’

Forward

5’ACAAGGCTGCCCCGACTAT3’

Reverse

5’ CTCCTGGTATGAAGTGGCAAATC3’

Forward

5’ TACCTATGTCTTGCCCGTGGAG3’

Reverse

5’ ATCATCCCACGAGTCACAGAGG3’

Forward

5’ AGCAGGATGCTGAGGATTCTG3’

Reverse

5’ GGCAACTCTGTCCTGCACCTA3’

Forward

5’GTGGCCTCTGTCATCTTCCG3’

Reverse

5’ CCGTCACCATCAGAGCAACG3’

Forward

5’ AGCAAAAGAGGCAACCAAGA3’

Reverse

5’ GGGTAAGGAATGGGATGGTT3’

Forward

5’ GGAAGCTGCGAGAAAAGAGA3’

Reverse

5’ TGAAAGTAACCTGGCCATCC3’
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3.5 TDNF Effects in the Lung

3.5.1 Histopathology of the Lung
Lung samples were fixed in 10% neutral buffered formalin for at least 48 hours, trimmed,
routinely processed for histology, sectioned at 4-µm thickness, and stained with hematoxylin and
eosin. Histologic changes were evaluated subjectively on a scale from 0 to 3, with 0=none,
1=mild, 2=moderate, and 3=marked.
Pathological assessment of the lung is shown in Figure 13. Anatomical evaluation
showed no significant changes between the animals that ingested TDNF and control groups.

3.5.2 Serum Total Protein
Significant reductions in total protein concentration in animals that ingested TNDF in
comparison to the control groups (Figure 14). Serum total protein concentration was significantly
reduced in animals that ingested TDNF. During the course of the experiment the Total Protein
of the lungs was analyzed. The total protein test quantifies the amount of albumin and globulins
in the blood vessels, which are responsible for preventing leaks and helping the immune system,
respectively. Thus, any deviation from normal or expected total protein concentrations can prove
detrimental to the tissue and even the organism. When looking at the total protein graph one can
tell that there is a decrease in total protein when comparing the control groups to the treated
groups. There is also a slight decrease in the total protein amount when comparing the medium
dose group to the low dose group.18
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3.5.3 Assessing Genome-wide Effect of TNDF
Additional adverse effects were examined in the genome-wide mRNA expression of the
lung. The goal was to assess the differential expression of unique gene transcripts in the lung.
Volcano plot of differentially expressed that were at least 2-fold up- or down-regulated are
represented in Figure 15. Blue or red dots indicate a gene. Up- and down-regulated genes were
those falling outside of the pair of marker lines of fold change of -2 to +2 as seen in Figure 15A,
B & C. Numbers of transcripts decoded from Figure 15 is plotted as a Venn diagram in Figure
16. Rats that ingested more TNDF also had a higher number of differentially expressed
transcripts. Comparison of the control group and 40 ppm-treatment group showed 39
significantly changed transcripts. The comparison of the control group to the 60 ppm treatment
group and the comparison of the 40 ppm treatment group to the 60 ppm treatment group showed
58 and 57 significantly changed genes, respectively.
The differentially expressed genes within the TNDF treated groups seem to play essential
roles in cellular immunity. Some of these include; CD209 antigen-like protein, immunoglobulin
heavy chain alpha, and hepacam2 (immunoglobulin superfamily of cell adhesion molecules)
(Table 4). Cd209 is reported to be crucial for modulating endogenous glycoprotein clearance.19
Both treatment groups indicate an over-expression of immunoglobulin heavy chain, alpha (Igha)
transcript. This particular gene is vital for immune responses. It blocks viral attachment as well
as neutralizing virus infectivity.20 From the preceding, one can deduce that the fibers are too long
to penetrate the cell, however they may serve as a phagocytosis site at the point of deposit that
can lead to inflammation.
Mapping of significantly changed genes onto pathways may be important to understand
the adverse effects associated with TDNF exposure (Table 5). Several pathways from KEGG
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were identified to be relevant to assessing the toxicity of TNDF. Some of these are TNF
signaling pathway, Cytokine-cytokine receptor interaction, cAMP signaling pathway, MAPK
signaling pathway, chemokine signaling pathway and inflammatory mediator regulation of TRP
channels.

3.5.4 Igha mRNA Levels in response to TDNF Ingestion
Clinical chemistry and morphometric indices can provide insightful knowledge regarding
the short-term effect of TDNF ingestion. Nevertheless noting changes at the molecular level via
these techniques will not be apparent. Global gene expression analysis provides the opportunity
to examine transcriptional modifications in biological systems.21 This will provide an
understanding of toxic effects at the molecular level.
Quantitative measurement of IgA (immunoglobulin A) was undertaken in lungs as a way
to validate microarray data. IgA is the principal line of defense against pathogens and other
foreign materials.22 The Ig heavy chain alpha has been reported to play crucial roles in cellular
transcription and recombination.23 To assess the validity of broad gene expression patterns, the
Igha transcript was quantified in lung tissues.
Genome-wide differential gene expression data was validated using quantitative PCR
analysis of the Igha gene. Global gene expression data showed that Igha was down-regulated in
the low concentration group while up-regulated in the 60ppm treated group. However the qPCR
data indicated that Igha mRNA was over-expressed in the FLC and FMC treated rats compared
with control groups (Figure 17). Still the medium concentration animals expressed higher levels
of the Igha than the low concentration group. A study a few years ago assessing the toxicity of
subchronic exposure to TCDD (2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin) found Igha was down-
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regulated in the liver of rats.24 Another study recently revealed that airways proteins such as Igha
(IgA constant region) was found to be affected by exposure to glutathione reaction product and
methylene-diphenyl diisocyanate (MDI).25
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FC

FLC

FMC

Figure 13. Anatomic characterization of select H&E images of lungs of male Sprague Dawley
rats exposed to 0 ppm (FC), 40 ppm (FLC), and 60 ppm (FMC) for two weeks via oral gavage.
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Figure 14. Total protein concentration in the serum of Sprague Dawley rats ingested 0 ppm
(FC), 40 ppm (FLC) and 60 ppm (FMC) Titanium Dioxide Nanofibers for two weeks. Total
Protein levels were significantly (p<0.05) reduced in rats that ingested TDNF.
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A

B

C

Figure 15. Volcano plot of lung differentially expressed genes from TDNF exposed rodents. The
plot of p-value relative to fold-change shows comparison between control and treated groups; A)
control vs low concentration (40 ppm), and control vs medium concentration (60 ppm).
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Figure 16. Venn diagram shows connection of significantly (p<0.05) altered genes between
groups. Comparing 0ppm vs 40ppm showed a total of 39 genes differentially expressed while
0ppm vs 60ppm and 40ppm vs 60ppm indicated 58 and 57 transcripts respectively. There were
no common gene expressed in all three of the groups.
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Table 4. Select number of altered mRNA transcripts between the groups. These genes were
extracted from Figure 2A which showed 16 genes to be common to all dose regimes.
Control vs 40ppm Treatment Group
Gene_assignment

Gene Symbol

p-value(0
ppm vs. 40
ppm)

Ratio(0
ppm vs.
40 ppm)

Fold-Change(0 ppm vs.
40 ppm) (Description)

0.402987

FoldChange(0
ppm vs. 40
ppm)
-2.48147

XM_003752548 // LOC100912723 // CD209
antigen-like protein A-like // --- // 100912723
XM_006221059 // LOC102551003 // keratinassociated protein 20-2-like // --- // 10255100
BC087057 // Igha // immunoglobulin heavy
chain, alpha // 6q32 // 314487
NM_001191973 // Ccdc129 //

LOC100912723

0.0109

LOC102551003

0.0106

2.082

2.082

0 ppm up vs 40 ppm

Igha

0.0356

0.290157

-3.4464

0 ppm down vs 40 ppm

Ccdc129

0.0405

0.492741

-2.02947

0 ppm down vs 40 ppm

Gene_assignment

Gene Symbol

p-value(0
ppm vs. 40
ppm)

Ratio(0
ppm vs.
40 ppm)

Fold-Change(0 ppm vs.
40 ppm) (Description)

ENSRNOT00000039185 // Hps5 // HermanskyPudlak syndrome 5 // 1q22 // 308598 ///
ENSRNOT
ENSRNOT00000048829 // RGD1564184 //
similar to monoclonal antibody 17-1A, light
chain /
FQ234364 // IgG-2a // gamma-2a
immunoglobulin heavy chain // 6q32 // 367586
ENSRNOT00000038646 // Igl //

Hps5

0.0042

2.15772

FoldChange(0
ppm vs. 40
ppm)
2.15772

RGD1564184

0.0099

2.43501

2.43501

0 ppm up vs 60 ppm

IgG-2a

0.0197

2.14326

2.14326

0 ppm up vs 60 ppm

Igl

0.0342

5.09259

5.09259

0 ppm up vs 60 ppm

Gene Symbol

p-value(0
ppm vs. 40
ppm)

Ratio(0
ppm vs.
40 ppm)

Fold-Change(0 ppm vs.
40 ppm) (Description)

NM_001106580 // Hepacam2 // HEPACAM
family member 2 // 4q13 // 296846 ///
ENSRNOT000000
XM_003752548 // LOC100912723 // CD209
antigen-like protein A-like // --- // 100912723
NM_173139 // Gnat3 // guanine nucleotide
binding protein, alpha transducing 3 // 4q11 /
XM_001068656 // Rgs13 //

Hepacam2

0.0071

2.15206

FoldChange(0
ppm vs. 40
ppm)
2.15206

LOC100912723

0.0180

2.23899

2.23899

40 ppm up vs 60 ppm

Gnat3

0.0081

2.02105

2.02105

40 ppm up vs 60 ppm

Rgs13

0.0120

3.09498

3.09498

40 ppm up vs 60 ppm

NM_053333 // Retnla // resistin like alpha //

Retnla

0.0131

2.93234

2.93234

40 ppm up vs 60 ppm

XM_006255431 // LOC685226 //

LOC685226

0.0170

2.26691

2.26691

40 ppm up vs 60 ppm

XM_002727416 // LOC685989 //

LOC685989

0.0190

2.25025

2.25025

40 ppm up vs 60 ppm

XM_006255431 // LOC685226 //

LOC685226

0.0212

2.3786

2.3786

40 ppm up vs 60 ppm

BC087057 // Igha //

Igha

0.0413

3.27428

3.27428

40 ppm up vs 60 ppm

NM_017146 // Mcpt10 //

Mcpt10

0.0261

3.77258

3.77258

40 ppm up vs 60 ppm

XM_006227158 // LOC679730 //

LOC679730

0.0379

2.34971

2.34971

40 ppm up vs 60 ppm

XM_006227158 // LOC679730 //

LOC679730

0.0368

2.32343

2.32343

40 ppm up vs 60 ppm

0 ppm down vs 40 ppm

Control vs 60ppm Treatment Group

40ppm vs 60ppm Treatment Group
Gene_assignment

0 ppm up vs 60 ppm

40 ppm up vs 60 ppm
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XM_003748679 // LOC501467 // s

LOC501467

0.0388

3.38318

3.38318

40 ppm up vs 60 ppm

NM_001108388 // Scel // sciellin //

Scel

0.0364

0.220588

-4.53334

XM_003748679 // LOC501467 //

LOC501467

0.0387

3.09909

3.09909

40 ppm down vs 60
ppm
40 ppm up vs 60 ppm

XM_006255043 // LOC689453 //

LOC689453

0.0465

3.63195

3.63195

40 ppm up vs 60 ppm

XM_003748679 // LOC501467 //

LOC501467

0.0441

2.8232

2.8232

40 ppm up vs 60 ppm

XM_003751851 // LOC679730 //

LOC679730

0.0472

2.57289

2.57289

40 ppm up vs 60 ppm
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Table 5. Pathways assessed to be significantly (p<0.05) altered by oral ingestion of TDNF using
KEGG (Kyoto Encyclopedia of Genes and Genomes). Percentage of genes involved in each
pathway ranged from 97 to 103.
Pathway Name

Enrichment
Score

Enrichment
p-value

% genes in pathway
that are present

# genes in list,
in pathway

cAMP signaling pathway

9.87006

5.17E-05

100.518

194

Adrenergic signaling in cardiomyocytes

7.37151

0.000629

101.399

145

FoxO signaling pathway

6.72035

0.001206

100

133

Chemokine signaling pathway

6.59099

0.001373

99.4318

175

Cytokine-cytokine receptor interaction

6.54372

0.001439

99.0654

212

Hepatitis C

6.15986

0.002113

100

122

Sphingolipid signaling pathway

6.10895

0.002223

100

121

Protein processing in endoplasmic reticulum

6.08662

0.002273

99.3939

164

Thyroid hormone signaling pathway

5.90538

0.002725

100

117

Oxytocin signaling pathway

5.67723

0.003423

99.359

155

Oocyte meiosis

5.62983

0.003589

101.835

111

Insulin resistance

5.60023

0.003697

100

111

Cholinergic synapse

5.54939

0.00389

100

110

TNF signaling pathway

5.39694

0.00453

100

107

Chagas disease (American trypanosomiasis)

5.14298

0.00584

100

102

Rap1 signaling pathway

5.09067

0.006154

98.5915

210

PI3K-Akt signaling pathway

5.04025

0.006472

97.8979

326

Choline metabolism in cancer

5.00387

0.006712

101.02

99

Signaling pathways regulating pluripotency of stem cells

4.9129

0.007351

99.2806

138

Phosphatidylinositol signaling system

4.90211

0.007431

101.042

97

Melanogenesis

4.83845

0.007919

100

96

Circadian entrainment

4.78773

0.008331

100

95

Estrogen signaling pathway

4.74952

0.008656

101.075

94

Toll-like receptor signaling pathway

4.68629

0.009221

100

93

Glycerophospholipid metabolism

4.68629

0.009221

100

93

cGMP-PKG signaling pathway

4.66842

0.009387

98.8166

167

Proteoglycans in cancer

4.59698

0.010082

98.5

197

Neuroactive ligand-receptor interaction

4.51988

0.01089

97.9167

282

GnRH signaling pathway

4.4835

0.011294

100

89

Progesterone-mediated oocyte maturation

4.39373

0.012355

101.163

87

Prostate cancer

4.39373

0.012355

101.163

87

Axon guidance

4.38141

0.012508

99.2126

126

Dopaminergic synapse

4.38141

0.012508

99.2126

126

Endocytosis

4.36019

0.012776

97.8799

277
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MAPK signaling pathway

4.35599

0.01283

98.0315

249

Insulin secretion

4.29213

0.013676

101.19

85

TGF-beta signaling pathway

4.1398

0.015926

101.235

82

Hippo signaling pathway

4.02961

0.017781

98.6928

151

Calcium signaling pathway

3.89601

0.020323

98.3425

178

Glutamatergic synapse

3.77121

0.023024

99.115

112

Prolactin signaling pathway

3.73386

0.0239

101.37

74

Pathways in cancer

3.71438

0.024371

97.2152

384

Inflammatory mediator regulation of TRP channels

3.68501

0.025097

99.0991

110

Gastric acid secretion

3.62288

0.026706

100

72

Melanoma

3.58176

0.027827

101.429

71

Bile secretion

3.53107

0.029274

101.449

70

Ras signaling pathway

3.51735

0.029678

97.807

223

Thyroid hormone synthesis

3.47121

0.031079

100

69

Renin secretion

3.37904

0.03408

101.515

67

Glioma

3.28637

0.037389

103.175

65

Fc epsilon RI signaling pathway

3.27773

0.037714

101.563

65

Amphetamine addiction

3.27773

0.037714

101.563

65

Long-term potentiation

3.23559

0.039337

103.226

64

Pancreatic cancer

3.22708

0.039673

101.587

64

Synaptic vesicle cycle

3.11757

0.044265

100

62

Glucagon signaling pathway

3.0894

0.045529

98.9691

96

Taste transduction

3.06708

0.046557

100

61

Pancreatic secretion

3.04742

0.047481

98.9583

95

AMPK signaling pathway

3.03243

0.048198

98.4252

125

VEGF signaling pathway

3.02456

0.048579

101.695

60

Long-term depression

3.02456

0.048579

101.695

60

Natural killer cell mediated cytotoxicity

2.96372

0.051627

98.9362

93
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Figure 17. Igha gene expression determined via quantitative real-time PCR. Igha was
significantly expressed in the FLC (low concentration - 40ppm) and FMC (medium
concentration - 60ppm) animals relative to the control (FC - 0ppm) group.
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Chapter 4 Summary and Conclusion
4.1 Kidney Effects
In summary, the short term effects of TDNF ingestion in Sprague Dawley rats was
performed. Titanium fibers ranged from 50 nm to 950 nm in diameter. TDNF consumption
seems to lead to a slight trend towards reduction in dietary ingestion. A literature search,
however, indicates a lack of other studies showing any such effects. TDNF exposure showed no
significant histopathological changes in renal tissues. However, LDH activity and Ti-47
concentration were found to be significantly elevated in the 40 ppm and 60 ppm rats. It has been
previously shown that high levels of Ti-47 caused serious inflammation or even small cell
lesions, which could correspond to the increased levels of LDH. This was followed with analysis
of specific mRNA transcripts that might provide insight into the molecular perturbations with
respect to TDNF ingestion. Up-regulation of NFKB likely indicates the involvement of renal
tissue inflammation via an independent mechanism. Similarly, Gadd45a was significantly over
expressed in kidney tissues. This transcript was previously increased following stressful growth
arrest conditions and treatment with DNA-damaging agents.

4.2 Liver Effects
The results indicate that TDNF (40 ppm and 60 ppm) is not toxic to the liver of Sprague
Dawley rats during a short-term exposure via oral gavage. No significant changes in
histopathological data, weight measurements, and serum ALB levels between 0 ppm and
experimental groups are suggestive of little toxicity. In order to confirm this hypothesis, the
hepatic effects of anatase-TDNF would need to be investigated in the future in addition to
prolonged exposure periods and higher concentrations of TDNF.
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4.3 Lung Effects
The present study was undertaken to examine the short-term toxicity associated with
TDNF ingestion. Lung weight and qualitative examination of the lung showed no significant
changes. However serum total protein and weight gain during the course of the study displayed
marginal concentration-dependent alterations. These findings were followed by global gene
expression analysis to identify which transcripts might be responsive to TDNF toxicity.
Differentially expressed mRNA levels were dose-dependently higher in animals exposed to
TDNF. It appears that the majority of the affected genes may be biochemically involved in
immune response and inflammation. We surmise that TDNF may be too long to penetrate the
cell, which may create a phagocytosis site and trigger inflammatory and immune response. All
results taken together show that short-term ingestion of TDNF may produce moderate effects
indicative of inflammation. Finally, the Igha gene was dose-dependently upregulated in treated
groups in a manner similar to patterns noted in the genome-wide results.
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